Diagnosis and pharmacotherapy of anxiety in older patients

Geriatrics and Aging

Volumn 8, Issue 5, 2005, Pages 37-41

  Morrow, Eric M ^a   Falk, William E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxiety; Benzodiazepines; Dementia; Depression; Psychotherapy; SSRIs

Indexed keywords

ACETYLSALICYLIC ACID; ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CAFFEINE; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLONAZEPAM; CLORAZEPATE; DIAZEPAM; DIGITALIS; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; HYDROXYZINE; HYPNOTIC AGENT; IMIPRAMINE; LORAZEPAM; NARCOTIC AGENT; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; OXAZEPAM; PAROXETINE; PLACEBO; QUETIAPINE; RISPERIDONE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; STEROID; TEMAZEPAM; THYROID HORMONE; VENLAFAXINE;

ACCIDENT; AGED; AGORAPHOBIA; ANTICHOLINERGIC EFFECT; ANXIETY DISORDER; ATAXIA; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; BRADYCARDIA; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DATA ANALYSIS; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG TOLERABILITY; FALLING; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; GERIATRIC CARE; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTENSION; INCREASED APPETITE; MANIA; MEDICAL PARAMETERS; MEDICAL RESEARCH; NAUSEA; NERVOUSNESS; NEUROLOGIC DISEASE; OBSESSIVE COMPULSIVE DISORDER; ORTHOSTATIC HYPOTENSION; OUTPATIENT DEPARTMENT; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOMOTOR DISORDER; PSYCHOTHERAPY; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SOCIAL PHOBIA; SOMNOLENCE; SYMPTOMATOLOGY; TARDIVE DYSKINESIA; TREATMENT PLANNING; WEIGHT GAIN;

EID: 20744454617     PISSN: 14888408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Blazer D, George LK, Hughes D. The epidemiology of anxiety disorders: an age comparison. In: Solzman C, Lebowitz BD, eds. Anxiety in the elderly: treatment and research. New York: Springer, 1991:53-80.
2. Baykey AA, Levy JK, Fernandez F. Diagnosis and management of anxiety in the geriatric patient. Clin Geriatrics 1998;6:10-21.
3. Blazer DG. Generalized anxiety disorder and panic disorder in the elderly: a review. Harvard Rev Psychiatry 1997;5:18-27.
4. Lenze EJ, Pollock BG, Shear K, et al. Treatment considerations for anxiety in the elderly. CNS Spectrums 2003;8(Suppl. 3):S6-13.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994.
6. Beekman AT, de Beurs E, van Balkom AJ, et al. Anxiety and depression in later life: co-occurrence and communality of risk factors. Am J Psychiatry 2000;157:89-95.
7. Taylor WD, Doraiswamy PM. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future. Neuropsychopharmacol 2004;29:2272-7.
8. Wylie ME, Miller MD, Shear MK, et al. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. J Geriatr Psychiatry Neurol 2000;13:43-8.
9. Sheikh JI, Lauderdale SA, Cassidy EL. Efficacy of sertraline for panic disorder in older adults: a preliminary open-label trial. Am J Geriatr Psychiatry 2004;12:230.
10. Bohm C, Robinson DS, Gammans RE. Buspirone therapy for elderly patients with anxiety or depressive neurosis. J Clin Psychiatry 1990;51:309.
11. Beekman AT, Bremmer MA, Deeg DJ, et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998;13:717-26.
12. Koepke JH, Gold RL, Linden ME, et al. Multicenter controlled study of oxazepam in anxious elderly outpatients. Psychosomatics 1982;23;641-5.
13. Bresolin N, Monza G, Scarpini E, et al. Treatment of anxiety with ketazolam in elderly patients. Clin Ther 1988;10:536-42.
14. Frattola L, Garreau M, Piolti R, et al. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients. Br J Psychiatry 1994;165:94-100.
15. Stanley MA, Beck JG, Novy DM, et al. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol 2003;71:309-19.
16. Wetherell JL, Gatz M, Craske MG. Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol 2003;71:31-40.
17. Barrowclough C, King P, Colville J, et al. A randomized trial of the effectiveness of cognitive-behavioral therapy and supportive counseling for anxiety symptoms in older adults. J Consult Clin Psychol 2001;69:756-62.
18. Goenjian AK, Najarian LM, Pynoos RS, et al. Posttraumatic stress disorder in elderly and younger adults after the 1988 earthquake in Armenia. Am J Psychiatry 1994;151:895-901.
19. Gleason PP, Schulz R, Smith NL, et al. Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998;13:243-50.
20. Wang PS, Bohn RL, Glynn RJ, et al. Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 2001;158:892-8.
21. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998;64:684-92.
22. Nemeroff CB. The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull 2003;37:133-46.
23. Pollack MH, Otto MW, Bernstein JG, et al. Anxious patients. In: Stern TA, Fricchione GL, Cassem NH, et al., eds. Massachusetts General Hospital, Handbook of general hospital psychiatry, 5th ed. Philadelphia: Mosby, 2004: 175-201.